Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001247640 | SCV001421074 | pathogenic | DiGeorge syndrome | 2019-12-11 | criteria provided, single submitter | clinical testing | This variant is an out-of-frame deletion of the genomic region encompassing part of exon 3 of the TBX1 gene. This is expected to create a premature translational stop signal and result in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with TBX1-related conditions. Loss-of-function variants in TBX1 are known to be pathogenic (PMID: 11239417, 11242049). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV003318675 | SCV004022553 | pathogenic | not provided | 2023-07-26 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |